Coronavirus Disease 19 (COVID-19) Pharmacologic Treatment
Keyword(s):
Since the first cases of COVID-19 were reported from China the disease became pandemic within a few months. The viral genome was sequenced soon after the outbreak of COVID-19 which enabled development of diagnostic tests and therapeutic options. As the knowledge of SARS-CoV-2 virology increased, many potential drugs appeared. At this moment (January 12th 2021), 4426 studies of COVID-19 are registered, and more than 2680 studies are investigating therapeutic options. This is a short narrative review of currently available evidence on pharmacological treatment of COVID-19.
2021 ◽
Vol 45
(2)
◽
pp. 104-121
Keyword(s):
2004 ◽
Vol 1
◽
pp. 23-25
◽
Keyword(s):
2012 ◽
Vol 286
(2)
◽
pp. 505-510
◽
Keyword(s):
2020 ◽
Keyword(s):
2019 ◽
Vol 32
(2)
◽
pp. 69-78
◽
2016 ◽
Vol 21
(2)
◽
pp. 120-132
◽